Search research articles
Contact Us
Filters
Showing results (71-80 of 272) with videos related to
Page
of 28
Sort By:
Cancers
|
October 14, 2020
Positron Emission Tomography in Merkel Cell Carcinoma
Christos Sachpekidis, Polytimi Sidiropoulou, Jessica C Hassel, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 12, 2025
Tofacitinib for treatment of a cortisone, mycophenolate mofetil and infliximab-refractory immune checkpoint inhibitor-mediated colitis in an advanced melanoma patient
Sophie C Reiser, Christina Naoum, Annika Gauss, et al.
Cancer Immunology, Immunotherapy : CII
|
July 16, 2022
Cytokine alterations during paraneoplastic neutrophilia and leukemoid reaction in patients with advanced melanoma
Xin-Wen Zhang, Alexander Wald, Martin Salzmann, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
December 20, 2016
Exanthematous cutaneous spread of metastatic urothelial carcinoma in a 69-year-old man
Mareen Salz, Antje Saborowski, Ferdinand Toberer, et al.
Diagnostics (Basel, Switzerland)
|
November 3, 2018
Retrospective Side Effect Profiling of the Metastatic Melanoma Combination Therapy Ipilimumab-Nivolumab Using Adverse Event Data
Theodoros G Soldatos, Antonia Dimitrakopoulou-Strauss, Lionel Larribere, et al.
Clinical Nutrition ESPEN
|
March 20, 2025
Influence of high-fiber diet on ipilimumab-induced gastrointestinal toxicity in metastatic melanoma
Pawel Majenka, Matthias Hoffmann, Sophia Strobel, et al.
Frontiers in Medicine
|
February 9, 2023
Rapid disease progression on immune checkpoint inhibitors in young patients with stage IV melanoma
Devayani Machiraju, Sarah Schäfer, Philip Beckhove, et al.
Cancers
|
April 3, 2021
Quantitative Dynamic <sup>18</sup>F-FDG PET/CT in Survival Prediction of Metastatic Melanoma under PD-1 Inhibitors
Christos Sachpekidis, Jessica C Hassel, Annette Kopp-Schneider, et al.
Cancer Immunology, Immunotherapy : CII
|
November 28, 2018
Can benign lymphoid tissue changes in <sup>18</sup>F-FDG PET/CT predict response to immunotherapy in metastatic melanoma?
Christos Sachpekidis, Lionel Larribère, Annette Kopp-Schneider, et al.
Future Oncology (London, England)
|
February 17, 2015
Histogram analysis of iodine maps from dual energy computed tomography for monitoring targeted therapy of melanoma patients
Monika Uhrig, David Simons, Maria-Katharina Ganten, et al.
Page
of 28
Search research articles
Search
Showing results (71-80 of 272) with videos related to
Sort By:
Page
of 28
Cancers
|
October 14, 2020
Positron Emission Tomography in Merkel Cell Carcinoma
Christos Sachpekidis, Polytimi Sidiropoulou, Jessica C Hassel, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 12, 2025
Tofacitinib for treatment of a cortisone, mycophenolate mofetil and infliximab-refractory immune checkpoint inhibitor-mediated colitis in an advanced melanoma patient
Sophie C Reiser, Christina Naoum, Annika Gauss, et al.
Cancer Immunology, Immunotherapy : CII
|
July 16, 2022
Cytokine alterations during paraneoplastic neutrophilia and leukemoid reaction in patients with advanced melanoma
Xin-Wen Zhang, Alexander Wald, Martin Salzmann, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
December 20, 2016
Exanthematous cutaneous spread of metastatic urothelial carcinoma in a 69-year-old man
Mareen Salz, Antje Saborowski, Ferdinand Toberer, et al.
Diagnostics (Basel, Switzerland)
|
November 3, 2018
Retrospective Side Effect Profiling of the Metastatic Melanoma Combination Therapy Ipilimumab-Nivolumab Using Adverse Event Data
Theodoros G Soldatos, Antonia Dimitrakopoulou-Strauss, Lionel Larribere, et al.
Clinical Nutrition ESPEN
|
March 20, 2025
Influence of high-fiber diet on ipilimumab-induced gastrointestinal toxicity in metastatic melanoma
Pawel Majenka, Matthias Hoffmann, Sophia Strobel, et al.
Frontiers in Medicine
|
February 9, 2023
Rapid disease progression on immune checkpoint inhibitors in young patients with stage IV melanoma
Devayani Machiraju, Sarah Schäfer, Philip Beckhove, et al.
Cancers
|
April 3, 2021
Quantitative Dynamic <sup>18</sup>F-FDG PET/CT in Survival Prediction of Metastatic Melanoma under PD-1 Inhibitors
Christos Sachpekidis, Jessica C Hassel, Annette Kopp-Schneider, et al.
Cancer Immunology, Immunotherapy : CII
|
November 28, 2018
Can benign lymphoid tissue changes in <sup>18</sup>F-FDG PET/CT predict response to immunotherapy in metastatic melanoma?
Christos Sachpekidis, Lionel Larribère, Annette Kopp-Schneider, et al.
Future Oncology (London, England)
|
February 17, 2015
Histogram analysis of iodine maps from dual energy computed tomography for monitoring targeted therapy of melanoma patients
Monika Uhrig, David Simons, Maria-Katharina Ganten, et al.
Page
of 28